ERBB2 and neoplasm: The increased expression of CDC7 has been linked to HER2-Enriched and triple-negative subtypes, accelerated cell cycle progression, arrested tumour differentiation and genomic instability during the tumorigenesis of mammary tissue and led to poorer disease-free survival [29].